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resumo 
 
 
O grafeno tem a espessura de um único átomo de carbono, de duas 
dimensões, arranjado de forma hexagonal e desde o seu isolamento, as suas 
propriedades têm sido bastante estudadas, sendo o grafeno e os materiais 
baseados no grafeno aplicados em diversas áreas. Vários tipos de 
nanomateriais de grafeno têm sido sintetizados e vastamente aplicados, 
contudo existe ainda algum desconhecimento acerca dos seus potenciais 
efeitos na saúde humana, sobretudo porque estes nanomateriais podem ser 
facilmente inalados, especialmente no processo de manufatura, caso não 
existam os devidos cuidados. 
Neste trabalho, um conjunto de compostos de grafeno foram selecionados 
para avaliação do seu efeito citotóxico em macrófagos RAW264.7. Como 
referência foi usado o bem caracterizado negro de carvão. As células foram 
expostas às doses BMD30 e 0.5BMD30, definidas por estudos anteriores. Para 
tal avaliou-se o grau de internalização das diferentes GFNs (família dos 
nanomateriais de grafeno) pelas células RAW264.7, assim como os potenciais 
efeitos oxidativos pela avaliação na produção de ROS. Os GFNs P4, P5 e P6 
foram selecionados para estudos adicionais devido ao seu alto potencial 
tóxico. Foram estudados os mecanismos de morte induzida para os GFNs P4, 
P5 e P6 pela avaliação da percentagem de células em apoptose / necrose e 
pelo potencial de membrana mitocondrial.  
Os resultados mostraram que todos os GFNs testados foram internalizados 
pelas células RAW 264.7, mas a P3, P4 e P5 (carboxil grafeno, nanoplaquetas 
de grafeno e óxido de grafeno de camada única, respetivamente) foram 
internalizados em proporções mais altas. Para P1, P2, P3, P5 e P6, observou-
se um aumento na internalização de nanomateriais dependente da duração de 
exposição aos mesmos. Além disso, os GFNs P2, P3, P4, P6 e P8 mostraram 
um aumento da produção de ROS nas concentrações de 0.5BMD30, mas não 
nas concentrações de BMD30. Os resultados mostraram que P4 e P5 
aumentaram o número de células apoptóticas e a diminuíram o potencial da 
membrana mitocondrial nas células RAW 264.7. 
Em geral, os nossos resultados demonstraram que a toxicidade dos GFNs é 
amplamente dependente das suas características físico-químicas, sugerindo 
que de todos os GFNs estudados, os P4 e P5 (nanoplaquetas de grafeno e pó 
de óxido de grafeno de camada única, respetivamente) foram os mais 
citotóxicas para as células RAW264.7. 
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abstract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graphene is a single-atom thick, two-dimensional sheet of hexagonally 
arranged carbon atoms and since its isolation, its properties have been widely 
studied, and graphene and graphene-based nanomaterials are now applied in 
several fields. Several types of graphene-family nanomaterials (GFN) have 
been synthesized and widely applied, but there is still some misunderstanding 
about their potential effects on human health, especially since these 
nanomaterials can be easily inhaled, especially in the manufacturing process, 
if they are not properly cared for.  
In this work, a set of graphene family compounds were selected for the 
evaluation of their cytotoxic effects on RAW264.7 macrophages. The well-
characterized Carbon black nanomaterial was used as reference. Cells were 
exposed to the BMD30 and 0.5 BMD30 doses defined in previous studies. 
The internalization of the different GFNs (graphene-family nanomaterials) 
compounds by RAW264.7 cells was evaluated, as well as its potential 
oxidative effects by the evaluation of the production of reactive oxygen 
species (ROS). The GFNs P4, P5 and P6 were selected for further studies 
due to their highest toxicity potential. The mechanisms of GFNs induced cell 
death were studied for P4, P5 and P6 by the evaluation of the percentage of 
cells under apoptosis/necrosis and the mitochondrial membrane potential.  
The results showed that all the GFNs tested were internalized by RAW 264.7 
cells, but P3, P4 and P5 (carboxyl graphene, graphene nanoplatelets and 
single layer graphene oxide, respectively) were internalized at higher ratios. 
For P1, P2, P3, P5 and P6 an increase in nanomaterial internalization with 
exposure duration was observed. Furthermore, the GFNs P2, P3, P4, P6, and 
P8 showed an increase of ROS production at 0.5BMD30 but not at BMD30 
concentrations. The results showed that P4 and P5 increased the number of 
apoptotic cells and decreased mitochondrial membrane potential of RAW 
264.7 cells. 
Overall our results demonstrate that the toxicity of GFNs is widely dependent 
on their physico-chemical characteristics, suggesting that from all the GFNs 
studied, P4 and P5 (graphene nanoplatelets and single layer graphene oxide 
powder, respectively) were the most cytotoxic to RAW264.7 cells. 
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I. Introduction 
Nano Etymology and Classification 
 
Nanomaterials, considered the building blocks for nanotechnology, are engineered 
materials with one or more components with at least one dimension measuring 
100 nm or less. The current definition of nanomaterial is the one adopted by the 
European Union in 2011, in which a nanomaterial is “a natural, incidental or 
manufactured material containing particles, in an unbound state or as an 
aggregate or as an agglomerate and where, for 50 % or more of the particles in 
the number size distribution, one or more external dimensions is in the size range 
1 nm - 100 nm” (Fig.1). In addition, “By derogation from the above, fullerenes, 
graphene flakes and single wall carbon nanotubes with one or more external 
dimensions below 1 nm should be considered as nanomaterials” (European 
Commission 2011). 
 
 
Figure 1: A size comparison of nanoparticle with other larger-sized materials. Adapted from Amin et 
al., 2014 
 
Nanoparticles can be then classified according to their size and also according to 
their dimensions (1D, 2D, 3D); their morphology, as for instance flatness, 
sphericity and aspect ratio; their composition, if they are composed of single 
material or several materials; their uniformity and agglomeration (Buzea et al., 
2 
 
2007). Therefore, in the category of nanomaterial are included the nanoparticles, 
nanofibers and nanotubes, composite materials and nano-structured surfaces 
(Bussy et al., 2012). The International Organization for Standardization defined the 
term nano-object as a material with one, two or three external dimensions in the 
nanoscale, shown in Fig. 2. Nanoparticles can have different shapes or crystalline 
form, and their surfaces can act as transporters for liquid droplets or gases. In a 
certain way nanoparticulate matter should be considered a distinct state of matter, 
in addition to the solid, liquid, gaseous, and plasma states, due to its distinct 
properties (Buzea et al., 2007). 
 
     
Figure 2: The different Nano-Objects. Adapted from Omlor et al.,2015 
 
 
Nanotechnology 
 
The concept of nanotechnology was introduced by the Nobel Prize laureate 
Richard Feynman, in 1959 in his lecture in the meeting of the American Physical 
Society “There’s plenty room at the bottom” (Feynman, 1960). However, the term 
Nanotechnology was first coined only several years later by the Japanese 
researcher Norio Taniguchi, in 1974 (Stern and McNeil, 2008). 
Nanotechnology can be defined as the design, synthesis, and application of 
materials and devices whose size and shape have been engineered at the 
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nanoscale. It exploits unique chemical, physical, electrical, and mechanical 
properties that emerge when matter is structured at the nanoscale (Buzea et al., 
2007). Nanotechnology is a promising molecular technology present in several 
areas of science and has many technological applications (Suzuki et al., 2007). 
With this, nanomaterials have increased their importance in the field of consumer 
products and nanodevices because of their unique structural, optical, 
physiochemical, magnetic, and surface characteristics (Suzuki et al., 2007; Kumar 
et al., 2011). 
Carbon-based Nanomaterials – Graphene Nanomaterials 
 
Carbon-based nanomaterials are a superfamily that includes fullerenes, carbon 
nanotubes (CNT), diamond, graphite and graphene, all of them allotropes of 
carbon (Hirsch 2010; Ma-Hock et al., 2013). In terms of scope of applications 
CNTs and graphene seem to be the more developed. Despite their common 
carbon-based elemental consistency, CNTs and graphene are two very distinct 
nanomaterial entities (Bussy et al., 2012). CNTs can be single-walled (SWCNT) or 
multi-walled (MWCNT) carbon sheets (Fig. 3) (Ma-Hock et al., 2013). Graphene is 
a more recent discovery, first isolated by Novoselov and Geim (Geim, 2009)  and 
consists of a a single-atom thick, two dimensional sheet of hexagonally arranged 
carbon atoms isolated from graphite, and is a strong and light material that 
conducts heat and electricity extremely well (Sanchez et al., 2012; Park et al., 
2014). Since graphene was isolated, its properties have been widely studied, and 
graphene and graphene-based nanomaterials are now applied in several fields, 
including electronics, energy storage, biosensors and biomedicine (Park et al., 
2015). 
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Figure 3: Scanning electron microscopy images of the test materials. A-D: agglomerate scale, 
E-H: primary structure scale. A, E: MWCNT, B, F: graphene, C, G: graphite nanoplatelets, D, H: 
Carbon Black. Note the same scale for MWCNT and Carbon Black, and slightly different set of 
scales for graphite nanoplatelets and graphene, in order to point to their individual characteristics. 
Adapted from Ma-Hock et al., 2013 
 
Graphene is one of the members of a much broader family of graphene-based 
materials, the Graphene-Family Nanomaterials (GFNs), and it includes few-layer 
graphene (FLG), graphene nanosheets (GNS), graphene oxide (GO) and reduced 
graphene oxide (rGO). They vary in layer number, lateral dimension, surface 
chemistry, defect density or quality of the individual graphene sheets, and 
composition and purity (Sanchez et al., 2012). 
GFNs have different preparation methods that can be classified into two 
categories: top-down organic synthetic approaches and bottom-up organic 
synthetic approaches. Top-down approaches, such as mechanical cleavage, the 
redox method, and arc discharge, utilize natural graphite as the carbon source and 
yield single- or few-layered graphene and GO through physical or chemical 
exfoliation or shear. Bottom-up approaches, such as CVD (Chemical vapor 
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deposition) and organic synthesis, utilize small carbon compounds to synthesize 
large single- or few-layered graphene and GO (Zhang et al., 2017). 
Graphene Applications 
 
Graphene has highly attractive properties such as high specific surface area, 
excellent electronic conductivity, thermal conductivity and mechanical strength, 
with this, graphene and its derivatives have revealed potential in several fields. In 
electronics, for example, it has been used for broadband and ultrafast photo-
detection and optical modulation. It is used for water filtration and desalination, in 
energy technology, sensors and catalysis, but biomedical application is a relative 
new area with substantial potential. The use of graphene in biomedicine has many 
applications, such as drug/gene delivery, biological sensing, and imaging, 
antibacterial materials, to biocompatible scaffold for cell culture and cancer 
treatments as detector of cancer biomarkers (Sanchez et al., 2012; Shen et al., 
2012; Sing,  2016;). 
Nanotoxicology and Graphene Toxicity 
 
Nanotoxicology was suggested as a new branch of toxicology to report the 
adverse health effects caused by nanoparticles (Buzea et al., 2007). Humans can 
be exposed to nanoparticles by several exposure routes, as for instance 
inhalation, ingestion, dermal penetration, injection or implantation for biomedical 
applications. Due to their small size, nanoparticles can translocate from these 
entry portals into the circulatory and lymphatic systems, and ultimately to tissues 
and organs. Some nanoparticles, depending on their composition and size, can 
produce irreversible damage to cells by oxidative stress and/or organelle injury. 
(Buzea et al., 2007; Sanchez et al., 2012). In a context of environment 
contamination or work place exposure, inhalation is a major route of exposure. 
The risk of exposure by inhalation is increased when GFNs are synthesized as dry 
powders using thermal exfoliation.  
Experimental studies in rodents demonstrated that instillation of SWCNT and 
MWCNT can cause pulmonary inflammation, granulomas, fibrosis, and ultimate 
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death. Therefore, the extensive use of graphene nanoparticles and their 
derivatives bring concerns regarding their safety (Stern and McNeil, 2008) and 
potential impact on the human health and the environment (Bussy et al., 2012; Ou 
et al., 2017). 
Inhalation is thought to be an important route of nanoparticle exposure because of 
their aerodynamic sizes that can lead to inhalation, traveling great distances in air, 
and substantial deposition in the human respiratory tract. This may impair lung 
defence and clearance leading to formation of granulomas and lung fibrosis 
(Suzuki et al., 2007; Stern and McNeil, 2008). Clearance mechanisms in the lung 
include the mucocilliary escalator and phagocytosis by alveolar macrophages, and 
some studies in rodents demonstrated that nanoparticles deposited in the lungs 
can translocate to the pulmonary interstitium (Stern and McNeil, 2008). Long-term 
and chronic exposure to GFNs may result in some diseases or harm health 
condition, for instance causing Parkinson’s disease- like symptoms by inducing 
cell apoptosis and senescence (Ou et al., 2017). 
The toxicity of GFNs depends of the dose, shape, surface chemistry, exposure 
route, and purity, and these properties play an important role in the toxicity of 
GFNs (Sing, 2016). GO demonstrated to induce cytotoxicity in several cell types, 
generation of ROS and decrease viability of cells (Wang et al., 2013), This effect 
was observed, for instance on HLF cells and A549 cells (Chang et al., 2011; Wang 
et al., 2013). Furthermore, in the kidney HEK293T cells GO caused DNA damage 
and loss of cell viability (Lu et al., 2017). GO nanosheets, in RAW264.7 cells, 
induced cell-cycle alterations, apoptosis and ROS (Matesanz et al., 2012). 
GO and rGO in HepG2 cells induced NADPH oxidase, ROS formation, apoptosis –
related genes expression and caused plasma membrane damage (Chatterjee et 
al., 2014). 
Pristine graphene in RAW264.7 cells can induce cytotoxicity through the depletion 
of the mitochondrial membrane potential (MMP), increase intracellular reactive 
oxygen species (ROS), then trigger apoptosis by activation of the mitochondrial 
pathway (Li et al., 2012; Rastogi et al., 2017), also in RAW264.7, resulted in 
elevated transcription and secretion of cytokines and chemokines and further alter 
the morphology and function of naïve macrophages (Zhou et al., 2012). 
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Graphene nanoplatelets (GNPs) down-regulated the generation of ROS, 
suppressed ATP production and caused mitochondria damage in BEAS-2B (Park 
et al., 2015). 
The still limited literature on in vitro toxicity propose that GFNs can be also benign 
or toxic to cells, and the biological reaction will differ through the material family 
depending on layer number, lateral size, stiffness, hydrophobicity, surface 
functionalization, and dose (Sanchez et al., 2012; Singh et al., 2011). 
Numerous groups have reported extremely low cytotoxicity and excellent 
biocompatibility of GO sheets. In contrast, some other groups have detected the 
cytotoxicity of graphene based materials due to the generation of harmful ROS, 
cell membrane damage by the sharp edge of graphene sheets, or wrapping the 
cells by aggregating graphene sheets in a suspension (Zhou et al., 2014). Particle 
numbers and surface area are important in the dose–response assessment of 
nanotoxicity. Size, shape, aggregation, surface functionalization/charge and the 
protein binding of the carbon nanomaterials may change the diffusion and 
sedimentation of these materials in cell culture systems, which directly influence 
the cellular dose of these materials, this can explain the controversial results in 
toxicity of graphene (Zhang et al., 2014; Zhou et al., 2014). 
II. Assay techniques and biomarkers to assess nanoparticle 
toxicity 
Uptake Potential of GFN´s 
 
The uptake of nanoparticles by cells is an important factor to assess nanotoxicity. 
Nanoparticles internalization by the cells can be identified by flow cytometry (FCM) 
by assessing the changes in light scattering or fluorescence. When particles are 
taken up by the cells the side-scatter (SS) intensity increases without change the 
forward-scatter (FS), as shown in Figure 4. This evaluation of uptake potential of 
nanoparticles using SS e FS is proper for initial screening of nanotoxicity (Ibuki 
and Toyooka, 2012). 
8 
 
Recent observations in biological systems suggest that the physical parameters of 
nanoparticles can affect their nonspecific uptake in cells, with potential to induce 
cellular responses (Jiang et al., 2008).  
 
Figure 4: Changes on flow cytometry light scattering upon exposure to nanoparticles. A- Control 
cells; B- Cells exposed to P4 
 
Cellular Uptake Mechanism 
 
Endocytosis is a common entry mechanism of several extracellular materials and 
the process is energy dependent, which means it will be hindered when 
incubations are carried out in an adenosine triphosphate (ATP)-depleted 
environment. The endocytosis pathway includes phagocytosis for larger foreign 
materials and pinocytosis for soluble materials or nanoparticles. Pinocytosis can 
be divided into four subcategories (Fig.5): macropinocytosis, for particles with a 
diameter between 0.5-5µm; clathrin-dependent endocytosis, for particles with a 
diameter between 200-500nm, and clathrin- and caveolae-independent 
endocytosis, for particles between 100-150nm (Huang et al., 2012).  
Macrophages are the ultimate cells of differentiation of the mononuclear 
phagocyte system, forming an important component of immunity doing 
phagocytosis of foreign bodies as well as in warning the rest of the immune 
system against invaders to cause innate or adaptive immune response. They are 
implicated in tissue repair and wound heling activities, being also a shield against 
A B 
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invading pathogens, toxicants or particles like graphene nanoparticles. If graphene 
nanoparticles originate toxicity to macrophages, there will be substantial damage 
in the immune resistance capacity of subjects (Arora et al., 2017; Sasidharan et 
al., 2012). 
 
              
Figure 5: Cellular Uptake Mechanism. Adapted from Kou et al., 2013 
 
Bussy, and co-workers (2012) summarised the main uptake mechanisms of GFNs 
following their interaction with membranes: phagocytosis, membrane adsorption 
and receptor-mediated endocytosis.  
 
Reactive Oxygen Species  
 
Reactive oxygen species (ROS) are important to intermediate in oxidative 
metabolism. However, when generated in excess, ROS can damage cells by 
peroxidising lipids and damaging structural proteins, enzymes and nucleic acids, 
resulting in necrosis, apoptosis or malignancy (Sing, 2016; Zhang et al., 2014). To 
evaluate the intracellular oxidative stress, the cell permeable oxidation-sensitive 
probe DCFH-DA may be used to determine the generation of ROS in the presence 
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of GFNs. DCFH-DA is a non-fluorescent molecule that can be easily transported 
across the cell membrane and deacetylate by esterase’s to form non-fluorescent 
2’,7’-dichloorfluorescin (DCFH), which becomes trapped inside the cells and gets 
further converted to highly fluorescent 2’,7’-dichloorfluorescein (DCF) in the 
presence of peroxidases (Zhou et al., 2014). 
As with other nanomaterials, a presumptive source of GFN cytotoxicity in 
eukaryotic cells is direct or indirect generation of intracellular ROS. An indirect 
source of intracellular ROS can result from impurities produced during GFN 
synthesis or chemical modifications of graphene. Direct sources of intracellular 
ROS include edge defects of graphene sheets or internal defects to GO sheets 
(for example) produced during synthesis. Both indirect and direct sources for GFN-
generated ROS have the potential to interfere with biochemical processes and 
induce cytotoxicity and genotoxicity (Zhang et al., 2014). 
Cellular Apoptosis 
 
Apoptosis or programmed cell death (PCD) defines a genetically-encoded cell 
death program, which is morphologically, biochemically and molecularly distinct 
from necrosis. Necrosis is only the passive result of cellular injury and apoptosis 
forms an integral part of normal physiological cell processes. Apoptosis ensures a 
balance between cell proliferation and cell death and plays a regulatory role in the 
control of the size of cell populations and tissues (Vermes et al., 2000). 
The apoptotic process is characterized by specific morphologic features, including 
loss of plasma membrane asymmetry and attachment, plasma membrane 
blebbing, condensation of the cytoplasm and nucleus, and internucleosomal 
cleavage of DNA (Hingorani et al., 2011; Ly et al., 2003; Vermes et al., 2000). 
Loss of plasma membrane asymmetry is one of the earliest features of apoptosis. 
In apoptotic cells, the membrane phospholipid phosphatidylserine (PS) is 
translocated from the internal to the outer leaflet of the plasma membrane, thereby 
exposing PS to the external cellular environment. Annexin V is a Ca2+ -dependent 
phospholipid-binding protein with high affinity for PS, and binds to exposed 
apoptotic cell surface PS. Annexin V can be conjugated to fluorochromes while 
retaining its high affinity for PS and thus serves as a sensitive probe for FCM 
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analysis of cells undergoing apoptosis. PS translocation leads to the loss of 
membrane integrity, which accompanies the later stages of cell death resulting 
from either apoptotic or death. Therefore, staining with Annexin V is typically used 
in conjunction with propidium iodide (PI) for identification of early and late 
apoptotic cells. Viable cells with intact membranes exclude PI, while the 
membranes of dead and damaged cells are permeable to PI. Consequently, cells 
that are considered viable are both Annexin V and PI negative, while cells that are 
in early apoptosis are Annexin V positive and PI negative, and cells that are in late 
apoptosis are Annexin V and PI positive and dead cells are Annexin V negative 
and PI positive (Fig.6) (Hingorani et al., 2011). 
 
                        
                                Figure 6: Identification of apoptotic cells by FCM 
 
Mitochondrial Membrane Potential 
 
Mitochondrial membrane potential (MMP) has an important role in intermediate the 
oxidative energy metabolism, specifically maintaining the physiological function of 
the respiratory chain to generate ATP, and is capable of producing energy that 
supports aerobic conditions (Gerencser et al., 2012; Gottlieb et al., 2013; Joshi 
and Bakowska, 2011).  
Several ways to indicate molecular probes and methods have been used to 
evaluate the electrical potential through the mitochondrial membrane, like the 
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Figure 7: RAW 264.7 Cells 
probe Rhodamine 123 (Joshi and Bakowska, 2011; Scaduto et al., 1999) 
distributes passively between the cytosol and mitochondria, where transmembrane 
dissemination depends of the membrane potential, so it will respond to both 
changes in mitochondrial potential and in plasma membrane potential. In case of 
collapse of MMP, a reduction in fluorescence intensity occurs (Ly et al., 2003). 
III. Cell Line RAW264.7 
 
The cell line RAW 264.7 is a macrophage cell line, isolated from Mus musculus 
(mouse) and this line was established from a tumour induced by Abelson murine 
leukaemia virus (Fig. 7). 
This cell line is easy to propagate, highly efficient for DNA transfection, sensitivite 
to RNA interference, and supports replication of murine noroviruses. 
The base medium for this cell line is ATCC-formulated Dulbecco's Modified 
Eagle's Medium (DMEM) whit 10% of glutamine, fungizone, pen-strep and fetal 
bovine serum (FBS) and their culture conditions are with the atmosphere at 95% 
of air, and 5% of carbon dioxide (CO2) and the temperature at 37°C. Regarding to 
the culture properties, RAW264.7 is adherent cells that grow in a nonolayer. 
(ATCC, 2016). 
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IV. Aims 
 
The general aim was to perform a comprehensive study on the cytotoxicity of 
seven graphene nanomaterials to macrophage RAW 264.7 cells using carbon 
black as reference, to establish a toxicity ranking. 
The specific aims of this work were: 
- To evaluate the internalization of the several GFNs at 0.5 BMD30 and 
BMD30 and to evaluate the influence of structure on the uptake potential by 
flow cytometry; 
- To study the potential of the several GFNs to induce ROS production in 
RAW 264.7 cells; 
- To evaluate the effect of GFNs on the induction and modulation of early and 
late apoptosis/necrosis; 
- To study the effects of GFNs on the mitochondrial membrane potential 
- To establish a cytotoxicity ranking of the several GFNs. 
 
V. Materials and Methods 
Test Materials and Characterization 
 
For the current study 7 GFNs compounds were selected (P1-P7) and carbon black 
(P8) was used as reference for particulate material (Table 1): 
 
P1. Single-Layer Graphene Powder; 
P2. Single-Layer graphene from factory series; 
P3. Carboxyl graphene; 
P4. Graphene nanoplatelets; 
P5. Graphene oxide powder (S method); 
P6. Graphite oxide powder; 
P7. Reference pristine graphene nanoplatelets; 
P8. Reference Carbon Black particles 
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Table 1: Shows the detailed information of the several nanomaterials 
 
Sample Source 
Product 
Diameter 
(µm) 
Thickness Specific 
surface (m
2
/g) 
   SEM 
 image 
Preparations/ 
Properties 
P1 
ACS 
GN1P 
0005 
~5 2-10 278 (400-1000) 
 
Thermal exfoliation reduction + 
 Hydrogen reduction 
P2 
ACS 
GN1PF 
0.5-5 2-10 620 (650-750) 
 
1-5 atomic layer graphene  
nanosheets 
P3 
ACS 
GN1PF 
010 
1-5 0.8-1.2 1.5 
 
1 – Modified Hummer’s method 
 to make graphene oxide; 
2 – Convert –OH and C-O-C  
into –COOH. 
Carboxyl ratio: 5% 
P4 
ACS 
GNNP 
0051 
~5 2-10 15 (20-40) 
 
Stacks of multi-layer graphene,  
with a high aspect ratio, 
 width to thickness 
P5 
ACS 
GNOS 
0010 
1-15 0.8-1.2 5.2 (5-10) 
 
Stauden-maier method;  
oxygen content: 35% 
P6 
ACS 
GTOP 
0002 
0.5-5 1-3 2.7 
 
Modified Hummer’s method:  
oxygen content: 35% 
P7 AVANZARE 2 3 195 (70) 
 No XPS (low defects by RAMAN) all 
CS1 carbons. 8±0.5 atomic 
 layer graphene 
P8 
Evonik- 
Degussa 
14 - 317 (337) 
 
Specified as >99% pure 
 carbon black 
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Cell Culture 
 
The RAW 264.7 cell line was kindly provided by Dr. Philipp Seib, University of 
Strathclyde (Glasgow, UK). Cell culture reagents were purchased from Life 
Technologies (Carlsbad, CA, USA). Cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM), supplemented with 10% fetal bovine serum (FBS), 2 
mM L-glutamine, 100 µ/mL penicillin, 100 μg/mL streptomycin, and 250 μg/mL 
fungizone, at 37 °C in 5% CO2 humidified atmosphere. 
Cells were regularly seen under an Eclipse TS100 inverted microscope (Nikon, 
Tokyo, Japan) to evaluate their morphology, confluence and screen for possible 
contaminations. The sub culturing process was done once the cells reached about 
70-80% of confluence of the flask surface available for cell growth. Then the old 
medium was removed, and the cells were washed with   phosphate buffered saline 
– PBS (Gibco). Cells were detached from the flask surface by scraping and then 
the cells were resuspended in culture medium and counted using a Neubauer 
Chamber. The desired number of cells were seeded into a new flask and then 
incubated at the culture conditions described above. The sub culturing process 
was performed two to three times per week. Standard aseptic techniques were 
followed throughout the experiments. 
GFNs exposure  
 
Cells were seeded in 12 and 6 well plates and incubated for 24h at 37°C, 5%CO2, 
for adherence. After the incubation period, the medium was removed and replaced 
for the same amount of the appropriate dilutions of GFNs. The concentrations for 
exposure were defined based in previous studies in whichRAW 264.7 cells were 
exposed to a range of 0.00-50.00 µg/cm2 GFNs for 24h and 48h and cell viability 
was assessed by AlamarBlue (AB) and lactate dehydrogenase (LDH) assays 
(Menezes et al, 2017). The benchmark dose 30 (BMD30) and 0.5 BMD30 of each 
GFN for 24h were selected for the cell exposure in the subsequent assays and are 
shown in detail in table 2 (Menezes et al., 2017). 
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Table 2: Concentrations of particles per area 
Particle 
Concentration for 
BMD30 (µg/cm2) 
Concentration for 
0.5BMD30 (µg/cm2) 
P1 46.8 23.4 
P2 50 25 
P3 22 11 
P4 25.3 12.65 
P5 29.4 14.7 
P6 23.6 11.8 
P7 50 25 
P8 50 25 
 
Uptake Potential of GFNs  
 
Cells were seeded in 6-well plates at 112x105 cells/mL for the analysis at 4h and 
1x105 cells/ml for the analyses at 24h then they were allowed to adhere for 24h. 
Then, the cells were exposed to each of the GNFs (P1-P7) and carbon black (P8) 
dispersed in culture medium at the concentrations of BMD30 and 0.5BMD30 
respectively and were incubated for 4h at 4ºC (for internalization inhibition) 4h at 
37ºC and 24h at 37ºC. 
After the incubation period, the cells were scraped, resuspended and collected. 
The uptake potential was assessed by flow cytometry (FCM) as previously 
described by (Suzuki et al., 2007). The flow cytometric forward scatter (FS), which 
gives information on the particles size, and the flow cytometric side scatter (SS) 
information on complexity of particles, were measured using the Attune® Acoustic 
Focusing Cytometer (Applied Biosystems). At least 20 000 cells were analysed for 
each test. The data were analysed by FlowJo software (FlowJo LLC, Ashland, OR, 
USA). 
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Reactive Oxygen Species (ROS) 
 
Cells were seeded in 12 wells plates at 1x105 cells/mL and allowed to adhere for 
24h. Then the cells were exposed to each of the GFNs P1-P7 and carbon black 
(P8) dispersed in complete culture medium at the concentrations of BMD30, 
0.5BMD30 and incubated for 24h at 37ºC. The control cells were incubated in 
complete culture medium. 
The intracellular levels of ROS were assessed by the oxidation-sensitive probe 
DCFH-DA. ROS detection was assessed as previously described by Zhou, et al., 
(2014). After the 24h exposure period, cells were incubated at 37 ºC for 30 min in 
the dark with fresh medium containing 10 µM DCFH-DA. Thereafter cells were 
washed with PBS, scraped from the plate wells and resuspended in DMEM 
medium with 2% of FBS and then collected for analysis by FCM with an Attune® 
Acoustic Focusing Cytometer (Applied Biosystems) equipped with a 488nm laser. 
At least 30 000 events were analysed for each test.  The data were analysed by 
FlowJo software (FlowJo LLC, Ashland, OR, USA). 
Detection of Apoptosis (Annexin V-FITC/PI Assay) 
 
Cells were seeded in 12-well plates at 1x105 cells/mL and allowed to adhere for 
24h. Then, the cells were exposed to the GFNs (P4, P5 and-P6) dispersed in 
complete culture medium at the concentrations of BMD30, 0.5BMD30 and 
incubated for 24h at 37ºC. The control cells were incubated in complete culture 
medium. 
Annexin V–fluorescein isothiocyanate (FITC)/propidium iodide (PI) dual staining 
(BD Biosciences, CA, USA) was employed to detect early/late apoptotic and 
necrotic cells, and assessed according to manufacturer. After incubation with 
various GFNs for 24 h, the cells were counted, washed two times with cold PBS 
and stained with Annexin V and PI. Typically, 1x105 cells were resuspended in 
binding buffer (100 μL) followed by the sequential addition of FITC-conjugated 
Annexin V (5μ L; Annexin V–FITC) and PI (5μL). After incubation for 15 min in the 
dark at room temperature, stained cells were resuspended in binding buffer (400 
μL) and directly analysed by FCM with an Attune® Acoustic Focusing Cytometer 
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(Applied Biosystems). At least 10 000 events were analysed for each test. The 
data were analysed by FlowJo software (FlowJo LLC, Ashland, OR, USA).  
Mitochondrial Membrane Potential (MMP)  
 
Cells were seeded in 12-well plates at 1x105 cells/mL and allowed to adhere for 
24h. Then, the cells were exposed to the GFNs (P4, P5 and P6) dispersed in 
complete culture medium at the concentrations of BMD30, 0.5BMD30 and 
incubated for 24h at 37ºC. The control cells were incubated in complete culture 
medium. After de incubation period, cells were washed with PBS and incubated 
with 5µg/ml-1 Rhodamine123 (Sigma-Aldrich) for 30 min, at 37ºC. The cells were 
washed with PBS, scraped and centrifuged at 800g for 5min, at 4ºC. The cell pellet 
was washed with 1ml PBS containing 1%BSA (Bovine Serum Albumin) and 
resuspended in 500µl of PBS containing 1%BSA and  5µg/ml-1 PI (Sigma-Aldrich). 
The cells were analysed by FCM with an Attune® Acoustic Focusing Cytometer 
(Applied Biosystems) at an excitation wavelength of 488 nm. At least 50 000 
events were analysed for each test. The data were analysed by FlowJo software 
(FlowJo LLC, Ashland, OR, USA). 
Statistical analysis 
 
The results are reported as mean ± standard deviation (SD) and for all 
experiments, at least 3 replicates, and 3 independent assays were performed. 
Data analysis were performed with the software SigmaPlot version 12.5 (Systat 
Software Inc.) and the statistical significance between control and exposed cells 
was performed by one-way ANOVA followed by the Dunn’s test as non-parametric 
test, and Holm-Sidak test for statistically significant difference in the parameters.  
A t-test was used to compare the effect of incubation temperature and duration on 
GFNs cellular uptake. Normality was tested by the Shapiro-Wilk test. The 
differences were considered statistically significant for p < 0.005. 
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VI. Results 
Cell Characterization  
 
Microscopic observations of cell cultures showed that GFNs exposure decreased 
cell confluence and increased the number of dead cells (Fig. 8). 
 
Figure 8: Microscopic images of RAW264.7. A – RAW264.7 cells in control conditions, B - 
RAW264.7 cells exposed for 24h to 0.5BMD30 of P4. 
 
Uptake Potential of GFNs  
 
The uptake potential of GFNs at 0.5BMD30 and BMD30 in RAW264.7 cells was 
determined by quantitative analysis of the intracellular SS and measured under 
three conditions: after a 4h incubation at 4ºC; after a 4h incubation at 37ºC; after a 
24h incubation at 37ºC. 
Figure 9 shows a representative example of SS vs FS plot of control sample and 
exposed to P4. Figure 10 shows that overall all the nanomaterials were 
internalized by RAW264.7 cells. For P1, P2, P3, P5, P6 and P7 both 0.5BMD30 
and BMD30 induced an increase in SS. For P4 an increase in SS was also verified 
but only for the BMD30. The increase in SS upon incubation at 4ºC may indicate 
adsorption of the nanomaterials to the cell surface. By comparing the 
internalization after 4h incubation at 4ºC to 37ºC an increase in SS is detected for 
all the nanomaterials tested at both concentrations in the case of P1, P2, P3, P5 
and P6. The effect of duration of the exposure on the levels of internalization was 
also tested. Results showed that for P2, P3, P4 and P5 the internalization 
increased with time for both 0.5BMD30 and BMD30 exposures. In the case of P1 
A B 
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this increase occurred only for 0.5 BMD30 and for P6 and P7 it occurred only for 
BMD30 (Fig. 11). 
 
 
 
 
 
 
Figure 9 : Uptake potential of P5 by RAW264.7 cells assessed by the 
side scattered light by flow cytometry. Orange - 4h at 37ºC; Blue - 4h at 
4ºC; Red - 24h at 37ºC 
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Figure 10: Uptake of GFNs in Raw 264.7 cells. (*) shows the statistically significance difference 
found upon exposure to GFN’s (P<0.005). Data shows means ±SD. 
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Figure 11: Uptake of GFNs in Raw 264.7 cells, Comparing the time and duration of exposure. 
(*) shows the statistically significance difference found upon exposure to GFNs (P<0.005). Data 
shows means ±SD. 
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Reactive Oxygen Species 
 
The quantification of intracellular ROS in RAW264.7 cells exposed to GFNs for 
24h is shown in Figures 12 and 13. The GFNs P2, P3, P4 and P6 and carbon 
black (P8) at 0.5BMD30 concentration induced an increased in ROS production. 
                           
Figure 12: ROS production detected by DCF fluorescence measured by FCM:  Orange- Control 
cells, Green- Cells exposed to P4 
 
 
 
Figure 13: Level of intracellular ROS upon exposure to GFNs. Raw264.7 cells were exposed to 
GFN’s and measured by FCM. (*) shows the statistically significant difference (P<0.005). Data 
shows means ±SD 
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Ranking of toxicity  
 
Figure 14 shows the toxicity rankings established based on BMD30 doses for each 
GFN and the levels of cellular uptake and the ROS production. 
 
         
               
           Figure 14:  Ranking of toxicity, comparing concentration, cellular uptake and ROS 
 
Cellular Apoptosis 
 
The Annexin V assay was performed in order to evaluate the potential of GFNs to 
induce apoptosis in RAW264.7 cells.  The GFNs P4 (Graphene nanoplatelets (2-
10nm thickness)), P5 (Graphene oxide powder (S method)) and P6 (Graphite 
oxide powder) were selected for this study. As shown in Figures 15 and 16, 
graphene nano-platelets (P4) induced at 0.5 BMD30 and BMD30 an increase in 
the percentage of late apoptotic/necrotic cells (A+,P+), and in early apoptotic cells 
(A+, P-). The percentage of live cells also decreased in both concentrations. 
Exposure to graphene oxide (P5) at both 0.5BMD30 and BMD30 also induced an 
increase in the percentage of late apoptotic/necrotic cells and a decrease in the 
percentage of live cells (Fig. 17). Exposure to graphite oxide (P6) did not induce 
any significant changes in the levels of apoptotic cells or live cells (Fig.18). 
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Figure16: Annexin V-FITC and PI assay for apoptosis assessment of Raw264.7 after 24h 
exposure to particle 4 and measured by FCM. (*) shows the statistically significant difference 
(P<0.005). Data shows means ±SD 
 
 
 
Figure 15: Cellular Apoptosis detected by Annexin-V fluorescence measured by FCM:  
A- Control cells, B- Cells Exposed to P4 
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Figure18: Annexin V-FITC and PI assay for apoptosis assessment of Raw264.7 after 24h 
exposure to particle 6 and measured by FCM. (*) shows the statistically significant difference 
(P<0.005). Data shows means ±SD 
Figure17: Annexin V-FITC and PI assay for apoptosis assessment of Raw264.7 after 24h 
exposure to particle 5 and measured by FCM. (*) shows the statistically significant difference 
(P<0.005). Data shows means ±SD 
 
 
 
Mitochondrial Membrane Potential 
 
The MMP was measured using the Rhodamine 123 assay by FCM, after 
RAW264.7 cells exposure to P4, P5 and P6 GFNs for 24h, as show in Figures 19 
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
80,00%
90,00%
A- , PI+ A+, PI+ A+, PI- A-, PI-
%
 o
f 
Ev
en
ts
 
Graphene oxide powder (S method) 
Control 0.5BMD30 BMD30
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
80,00%
90,00%
A-, PI+ A+, PI+ A+, PI- A-, PI-
%
 o
f 
Ev
en
ts
 
Graphite oxide powder 
Control 0.5BMD30 BMD30
* 
* 
* 
* 
* 
* 
27 
 
Figure 19: MMP detected by Rhodamine 123 fluorescence measured by FCM: A- 
Control cells, B – Cells exposed to P4 
and 20. Graphene nanoplatelets (P4) at both concentrations induced a decrease 
in MMP comparatively to the control. For graphene oxide (P5) it was observed a 
decrease in MMP but only for the highest concentration (BMD30). No changes in 
MMP were detected upon exposure to P6 at tested concentrations for 24h (Fig. 
20). 
          
 
 
 
Figure 20: Mitochondrial membrane potential assessment of Raw 264.7 after 24h exposure to 
particles 4, 5 and 6 and measured by FCM. (*) shows the statistically significant difference 
(P<0.005). Data shows means ±SD 
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VII. Discussion 
 
Nanomaterials such as graphene and its derivatives have been massively 
produced and attracted tremendous attention. Previous studies with different 
cellular or animal model have demonstrated that some of the graphene derivatives 
induced significant cytotoxicity and genotoxicity. It has been reported that the 
surface properties, shape, size, surface charge, stability and purity of the 
nanomaterials all contribute to the differential toxicity observed (Park et al., 2015; 
Wang et al., 2013). Also for graphene-based materials it was reported that the 
different physicochemical properties result in different cellular toxicities (Ou et al., 
2017; Zhang et al., 2014). 
In this work the cellular effects of well-characterized GFNs were investigated to 
address the influence of them in morphology and viability of RAW264.7 cells. 
Cellular uptake of nanoparticles is an important process and activates further 
biological effects inside the cell. To quantitatively evaluate the cellular uptake of 
GNFs flow cytometry was used and related the increase in flow cytometric side 
scatter (SS) intensity with an increase in intracellular GFNs. Cellular uptake results 
showed an increased in SS in all three conditions tested: 4h incubation at 4ºC, 4h 
incubation at 37ºC and 24h incubation at 37ºC. In the first condition, RAW264.7 
cells were exposed to the GFNs at 4º C during 4h, and both concentrations 
(0.5BMD30 and BMD30) in P2, P3, P5, and P6, and the concentration BMD30 in 
P1, P4 and P7 showed significant increase comparing with control. In the second 
condition, RAW264.7 cells were exposed to the GFNs at 37ºC during 4h and only 
P4 at 0.5BMD30 concentration didn’t show significant increase comparing with 
control. In the third condition the RAW264.7 cells were expose to the GFNs at 
37ºC during 24h and P1, P2, P3, P5, P6 and P7 in both concentrations, and the 
concentration BMD30 in P4 showed significant increase comparing with control. 
To evaluate the effect of incubation temperature and duration of exposure a t-test 
was perform. The results suggested that at 37ºC had more internalization of GFNs 
than 4ºC, as expected since at 4ºC the phagocytic activity is inhibited (Lee et al., 
2017). The duration of the exposure also influenced the internalization at 37ºC, 
because after 24h of exposure to GFNs more particle internalization occurred 
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specially for P1, P2, P3, P5 and P6. By comparing all the nanomaterials, those 
internalized at higher ratios were P3, P4 and P5 (carboxyl graphene, graphene 
nanoplatelets and graphene oxide powder, respectively). The differential 
mechanism of toxicity of GFNs can depend on their cellular uptake, as was 
described by Chatterjee and co-workers (2014) when exposed HepG2 to GO and 
rGO. Their results showed that GO (hydrophilic) has been internalized by the 
HepG2 cells, but rGO (hydrophobic) was adsorbed and aggregated at cell surface 
without (or lower) uptake influencing their toxicity. 
ROS can be generated either by direct pro-oxidant effect of the GFNs or 
endogenously upon interaction with cellular material. DCFH-DA probe was used to 
determine the generation of ROS in the presence of GFNs using FCM analysis. 
The internalization of the GFN’s had demonstrated influence in ROS production 
and in different ways. The nanomaterials P2, P3, P4, P6, and P8 showed an 
increase of ROS production at low toxicity levels (0.5BMD30) and not at BMD30 
concentrations. 
Comparing P4 and P7, both graphene nanoplatelets (2-10nm thickness) and 
reference pristine graphene nanoplatelets respectively, the results showed for P4 
a significant increase of ROS levels but not for P7. This difference may be 
explained by the highest nanomaterial internalization observed for P4. 
Higher ROS production has been often highlighted as a major cause for GFNs 
toxicity in several cell types. Previous studies in TPH-1 cells after layered 
graphene nanoplatelets exposure demonstrated loss of membrane integrity that 
could be due to generation of ROS (Jastrzebska et al., 2012). Yan and co-workers 
(2017) found a significant increase of ROS production after the exposure of THP-1 
cells to GO and rGO with greater expression in the latter. In RAW64.7 cells 
exposed to CNT, carbon-black and nano-graphite, Figarol and co-workers (2015) 
found increased ROS production in a dose-dependent manner. HepG2 cells upon 
exposure to GO and carboxyl graphene, showed dose and time-dependent 
cytotoxicity with plasma membrane damage and induction of ROS, but not at low 
concentrations (<4µg/ml) (Sing et al., 2016). A concentration-dependent ROS 
induction, after exposure to GO, was reported for human skin fibroblast 
(Jastrzebska et al., 2012) 
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Through the evaluation of cellular uptake and ROS generation this work 
demonstrated that GFNs produce cytotoxicity in dose- and time- dependent 
manners. 
Considering the ranking of toxicity, based on the concentration of nanoparticles 
per area that generate toxicity, the cellular uptake and ROS production show that 
P4, P5 and P6 are more toxic being P7 and P8 the less toxic to RAW264.7 cells. 
Therefore, P4, P5, and P6 were selected for further studies on the induction of 
apoptosis and effects on mitochondrial membrane potential. 
Apoptosis was assessed combining the probe Annexin V and PI and further 
evaluation by FCM analysis. The results showed that P4 and P5 increased the 
number of apoptotic cells. When the cells were exposed to P4 the results showed 
significant increase in late and early apoptosis and P5 in early apoptosis and 
necrosis, demonstrating that modulation of apoptosis exists when exposure to 
these nanomaterials. P6 didn’t show significant differences between control and 
exposed cells after 24h. Since previously described graphene is manufactured 
from graphite, and between P5 and P6 we can see that the latter, graphite oxide 
powder, didn’t produce toxicity contrarily to P5, graphene oxide powder (S 
method), demonstrating that the physico-chemical characteristics influence the 
toxicology. Ou and co-workers (2017) demonstrated that graphene layers 
(10µg/ml) exposed to PC12 cell line induced apoptosis by activation caspase-3 in 
a time-dependent manner. 
The mitochondrial membrane potential was assessed combining the probe 
Rhodamine 123 and PI, and then analysed by FCM. This experiment showed 
significant decrease in the MMP of P4 at both concentrations and P5 at BMD30 
concentration. P6 didn’t show significant differences between control and exposed 
cells after 24h. Disruptions of the MMP may cause severe physiological 
consequences including decrease in ATP synthesis, increase in ROS generation, 
and the redistribution of pro-apoptotic mitochondrial factors. 
Li and co-workers (2012) reported that when RAW264.7 cells were exposed to 
pristine graphene destroys the MMP and increases intracellular ROS to cause 
cytotoxicity and subsequently trigger apoptosis. Graphene also induces cytotoxic 
31 
 
effects and mitochondrial injury in human neuronal cells at dose of 10µg/ml 
(Jastrzebska et al., 2012). 
VIII. Conclusions – Future Perspectives 
 
This study demonstrated that the duration and time of exposure to the GFNs 
influence the internalization in RAW264.7 cells, and the exposure of GFNs 
influence the ROS production. The different levels of toxicity are widely dependent 
of their physico-chemical characteristic. 
Considering that humans are usually exposed to GFNs, especially at their 
manufacture, it is important to determine if or which GFNs are more cytotoxic. This 
study suggests that from all the GFNs studied, P4 and P5 (graphene nanoplatelets 
and single-layer graphene oxide powder, respectively) were the most cytotoxic to 
RAW264.7 cells and was successfully established cytotoxicity ranking of GFNs. 
For future studies the biological effects of GFNs, its genotoxic potential, can be 
assessed on different types of cells. Also, a deeper study on the mechanisms 
underlying cytotoxicity by GFNs could be performed, for instance, the analysis of 
cytochrome c to better understand the relation between mitochondrial physiology 
and the release of cytochrome in apoptosis initiation. ATP measurements, protein 
expression and autophagy studies are also recommended. 
Considering the position of graphene and its derivatives in the nanotechnology 
field in the lastet years, it is important to keep further research with fundamental 
and experimental studies. 
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